Citation

Yu KL, Sin N, Civiello RL, Wang XA, Combrink KD, Gulgeze HB, Venables BL, Wright JJ, Dalterio RA, Zadjura L, Marino A, Dando S, D'Arienzo C, Kadow KF, Cianci CW, Li Z, Clarke J, Genovesi EV, Medina I, Lamb L, Colonno RJ, Yang Z, Krystal M, Meanwell NA.: Respiratory syncytial virus fusion inhibitors. Part 4: optimization for oral bioavailability. Bioorg Med Chem Lett, Volume 17 (4), 2007

Authors

Cianci CW, Civiello RL, Clarke J, Colonno RJ, Combrink KD, D'Arienzo C, Dalterio RA, Dando S, Genovesi EV, Gulgeze HB, Kadow KF, Krystal M, Lamb L, Li Z, Marino A, Meanwell NA., Medina I, Sin N, Venables BL, Wang XA, Wright JJ, Yang Z, Yu KL, Zadjura L

Journal

Bioorg Med Chem Lett

Year

2007

DOI

10.1016/j.bmcl.2006.11.063

PubMed

17169560

Machine-readable

REST APIRDF